Zurcher Kantonalbank (Zurich Cantonalbank) Compugen LTD Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.57 - $3.33 $15,002 - $31,821	-9,556 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$4.09 - $7.16 $40,916 - $71,628	-10,004 Reduced 51.15%	9,556 $41,000
Q4 2020 Jan 28, 2021	BUY	$12.07 - $17.95 $28,473 - $42,344	2,359 Added 13.71%	19,560 $237,000
Q2 2020 Jul 28, 2020	BUY	$6.97 - $17.12 $119,890 - $294,481	17,201 New	17,201 $258,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

Silverarc Capital Management, LLC

1.5M
Shares

$2.27 Million
0.68% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.29M
Shares

$1.94 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.2M
Shares

$1.81 Million
1.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

1.09M
Shares

$1.65 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account